Polewaczyk James F's Form 4 filing
IDEXX Laboratories Inc (IDXX) · filed Dec 8, 2023
- Accession no.
- 0000874716-23-000145
- Filed
- Dec 8, 2023
- Trade date
- Dec 7, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $6.07M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Polewaczyk James FCIK 0001389046 | Officer (Executive Vice President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2023 | Common Stock | MOption exerciseAcquired | +4,956 | $206.94 | +$1,025,594.64 | 15,005.99 | Direct | |
| Dec 7, 2023 | Common Stock | MOption exerciseAcquired | +6,680 | $288.78 | +$1,929,050.4 | 21,685.99 | Direct | |
| Dec 7, 2023 | Common Stock | SSaleDisposed | −3,116 | $520.19F2 | −$1,620,912.04 | 18,569.99 | Direct | |
| Dec 7, 2023 | Common Stock | SSaleDisposed | −3,378 | $521.00F3 | −$1,759,938 | 15,191.99 | Direct | |
| Dec 7, 2023 | Common Stock | SSaleDisposed | −1,202 | $522.31F4 | −$627,816.62 | 13,989.99 | Direct | |
| Dec 7, 2023 | Common Stock | SSaleDisposed | −3,940 | $523.56F5 | −$2,062,826.4 | 10,049.99 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2023 | Common Stock | MOption exerciseDisposed | −4,956 | $0.00 | $0 | 755 | Direct | |
| Dec 7, 2023 | Common Stock | MOption exerciseDisposed | −6,680 | $0.00 | $0 | 2,226 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average price of the shares sold ranging from a low of $519.73 to a high of $520.73 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average price of the shares sold ranging from a low of $520.74 to a high of $521.235 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average price of the shares sold ranging from a low of $521.99 to a high of $522.935 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average price of the shares sold ranging from a low of $523.05 to a high of $523.885 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.